Filing Details
- Accession Number:
- 0001209191-17-018270
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-06 16:09:26
- Reporting Period:
- 2017-03-02
- Filing Date:
- 2017-03-06
- Accepted Time:
- 2017-03-06 16:09:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1461806 | G. Raymond Murphy | 311 Enterprise Drive Plainsboro NJ 08536 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-03-02 | 5,238 | $10.74 | 66,132 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-03-02 | 5,238 | $43.01 | 60,894 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-03-02 | 5,238 | $0.00 | 5,238 | $10.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-05-20 | No | 4 | M | Direct |
Footnotes
- On December 21, 2016, the common stock of Integra LifeSciences Holdings Corporation split two-for-one, resulting in the reporting person's ownership of one additional share of common stock for each share of common stock owned as of that date, as reflected in the totals listed on this Form 4.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $42.84 to $43.09.
- 25% of the stock options vested every quarter from the grant date of 5/20/2009.
- This employee's stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.